Agilent Technologies June 15th Short Interest Update

Agilent Technologies (NYSE:A) has shown a drop of 1.6% or 53,155 shares in the short positions. The bets have increased to 3,274,407 shares on June 15,2016 from 3,327,562 shares on May 31,2016. With respect to the floated shares, the shorts are 1%. The days to cover are calculated to be 2, using the standard per day volume of 1,740,366 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Agilent Technologies (NYSE:A): The stock opened at $44.56 on Friday but the bulls could not build on the opening and the stock topped out at $45.07 for the day. The stock traded down to $43.92 during the day, due to lack of any buying support eventually closed down at $44.12 with a loss of -5.48% for the day. The stock had closed at $46.68 on the previous day. The total traded volume was 5,263,644 shares.

The company shares have rallied 13.89% from its 1 Year high price. On Jun 23, 2016, the shares registered one year high at $46.68 and the one year low was seen on Oct 2, 2015. The 50-Day Moving Average price is $44.78 and the 200 Day Moving Average price is recorded at $40.66.

Agilent Technologies (NYSE:A) has tumbled 2.73% during the past week and has dropped 3.71% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 1.12%. Agilent Technologies (NYSE:A) has underperformed the index by 0.8% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.